title: Surgical treatment of obesity.
abstract: Obesity is very prevalent. Most treatments fail owing to hard-wired survival mechanisms, linking stress and appetite, which have become grossly maladaptive in the industrial era. Antiobesity (bariatric) surgery is a seemingly drastic, efficacious therapy for this serious disease of energy surfeit. Technical progress during the last two decades has greatly improved its safety. The surgical principles of gastric restriction and/or gastrointestinal diversion have remained largely unchanged over 40 years, although mechanisms of action have been elucidated concomitant with advances in knowledge of the molecular biology of energy balance and appetite regulation. Results of bariatric surgery in large case-series followed for at least 10 years consistently demonstrate amelioration of components of the insulin-resistance metabolic syndrome and other comorbidities, significantly improving quality of life. Furthermore, bariatric surgery has convincingly been demonstrated to reduce mortality compared with nonoperative methods. This surgery requires substantial preoperative and postoperative evaluation, teaching, and monitoring to optimize outcomes. In the absence of effective societal changes to restore a healthy energy balance, bariatric surgery is an important tool for treating a very serious disease.
authors.affiliation: Department of Surgery, State University of New York Downstate Medical Center, Brooklyn, NY 11203-2098, USA. jkral@downstate.edu
authors.forename: John G
authors.initials: JG
authors.lastname: Kral
authors.forename: Erik
authors.initials: E
authors.lastname: Näslund
mesh_terms: D050110:Bariatric Surgery / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D003362:Cost-Benefit Analysis; D006801:Humans; D009767:Obesity, Morbid / Q000503:physiopathology / Q000601:surgery*; D010353:Patient Education as Topic; D018579:Patient Selection; D011788:Quality of Life; D012307:Risk Factors; D016896:Treatment Outcome; D015431:Weight Loss / Q000502:physiology